# Epoetin Beta in Treating Anemia in Patients With Cervical Cancer

> **NCT00046969** · PHASE4 · COMPLETED · sponsor: **AGO Study Group** · enrollment: 450 (estimated)

## Conditions studied

- Anemia
- Cervical Cancer

## Interventions

- **BIOLOGICAL:** epoetin beta
- **DRUG:** cisplatin
- **RADIATION:** brachytherapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00046969
- **Lead sponsor:** AGO Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2013-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046969, "Epoetin Beta in Treating Anemia in Patients With Cervical Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00046969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*